The omega-3 story: Nutritional prevention of preterm birth and other adverse pregnancy outcomes

Obstetrical and Gynecological Survey

Volumn 56, Issue 5 SUPPL., 2001, Pages

  McGregor, J A ^a   Allen, K G D ^a   Harris, M A ^a   Reece, M ^a   Wheeler, M ^a   French, J I ^a   Morrison, J ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARACHIDONIC ACID; CYCLOOXYGENASE 2; DOCOSAHEXAENOIC ACID; ESSENTIAL FATTY ACID; HYDROXYICOSATETRAENOIC ACID; ICOSANOID; LEUKOTRIENE; LINOLENIC ACID; LIPOXYGENASE; OMEGA 3 FATTY ACID; PROSTACYCLIN; PROSTAGLANDIN; THROMBOXANE;

BREAST MILK; CHILDBIRTH; DIET SUPPLEMENTATION; DIET THERAPY; GESTATION PERIOD; HUMAN; INTRAUTERINE GROWTH RETARDATION; LACTATION; LOW BIRTH WEIGHT; MATERNAL HYPERTENSION; MATERNAL NUTRITION; MYOMETRIUM; NONHUMAN; PREECLAMPSIA; PREGNANCY; PREGNANCY COMPLICATION; PREMATURE LABOR; PROSTAGLANDIN SYNTHESIS; RETINA DEVELOPMENT; REVIEW;

CHILD; DIABETES MELLITUS; DIETARY SUPPLEMENTS; FATTY ACIDS, OMEGA-3; FEMALE; FISH OILS; GESTATIONAL AGE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; LACTATION; NUTRITION PHYSIOLOGY; NUTRITIONAL REQUIREMENTS; PREGNANCY; PREGNANCY OUTCOME; PROSTAGLANDINS;

EID: 0035002997     PISSN: 00297828     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006254-200105001-00001     Document Type: Review

References (88)

1. The control of labor
2. Prostacyclin and thromboxane change predicting clinical onset of preeclampsia: A multicenter prospective study
3. Role of essential fatty acids in the function of the developing nervous system
4. The role of long-chain polyunsaturated fatty acids in infant cognitive development
5. Randomized clinical trials of fish oil supplementation in high risk pregnancies. Fish Oil Trials in Pregnancy (FOTIP) team
6. Neurologic and developmental disability after extreme preterm birth
7. Placental delivery of arachidonic and docosahexaenoic acids: Implications for the lipid nutrition of premature infants
8. Long-term follow up studies of prematurely born infants. II. Influence of birth weight and gestational age on sequelae
9. Further on the association between retarded foetal growth and adult cardiovascular disease. Could low intakes of marine diet be a common cause?
10. Omega-3 fatty acids in health and disease and in growth and development
11. The relative importance of essential fatty acids of the linoleic and linolenic acid families
12. Linoleic acid deficiency: Changes in fatty acid pattern in female and male rats raised on α-linolenic acid deficient diet for two generations
13. Studies to determine the role rates of chain elongation and desaturation play in regulating the unsaturated fatty acid composition of rat liver lipids
14. Linolenic acid desaturation and chain elongation and rapid turnover of phospholipid (n-3) fatty acids in isolated rat liver cells
15. Studies on the regulation of arachidonic acid synthesis in isolated liver cells
16. Influence of diet on (n-3) and (n-6) fatty acids in monkey erythrocytes
17. Dietary omega-3 fatty acid deficiency and visual loss in infant rhesus monkeys
18. Biochemical and functional effects of prenatal and postnatal w3 fatty acid deficiency on retina and brain in rhesus monkeys
19. The essentiality of n-3 fatty acids for the development and function of the retina and brain
20. Essential fatty acid status of fetal plasma phospholipids: Similar to postnatal values obtained at comparable gestational age
21. Polyunsaturated fatty acids in the food chain in the United States
22. Fatty acid composition of umbilical arteries and veins: Possible implications for fetal EFA-status
23. Intrauterine fatty acid accretion rates in human brain: Implications for fatty acid requirements
24. Effects of supplementation with w3 long-chain polyunsaturated fatty acids on retinal and cortical development in premature infants
25. Extrauterine fatty acid accretion in brain: Implications for fatty acid requirements
26. Docosahexaenoic acid status of preterm infants at birth and following feeding with human milk or formula
27. Visual acuity development in healthy preterm infants: Effect of marine oil supplementation
28. Safety and efficacy of omega-3 fatty acids in the nutrition of very low birth weight infants: Soy oil and marine oil supplementation of formula
29. Rift Valley Lake fish and shellfish provided brain specific nutrition in early Homo
30. Long-chain polyunsaturated fatty acids, pregnancy, and pregnancy outcome
31. Regulation of COX-2 gene expression in rat uterus in vivo and in utero
32. Effective dimunition of amniotic prostaglandin production by selective inhibitors of cyclooxygenase type 2
33. The role of prostaglandins in human parturition
34. Causes of preterm delivery
35. 2 gel for cervical ripening
36. Primary prostaglandins in amniotic fluid in pregnancy and spontaneous labor
37. 2a concentrations in amniotic fluid in late pregnancy
38. Arachidonic acid metabolism by rabbit fetal membranes of various gestational ages
39. Changes in prostaglandin F and 13,14-dihydro-15-keto prostaglandin F concentrations in amniotic fluid at the onset of and during labour
40. 2a in amniotic fluid and plasma in spontaneous and induced labours
41. 2a during labour
42. The Uterus. Prostaglandins and their inhibitors in clinical obstetrics and gynaecology
43. Immunohistochemical localization of relaxin, prolactin and prostaglandin synthase in human amnion, chorion, and decidua
44. Immunohistochemical localization of prostaglandin endoperoxide synthase in human fetal membranes and decidual
45. Prostaglandins and human parturition: Regulation of arachidonic acid mobilization
46. 5-Hydroxy-eicosatetraenoic acid and human parturition
47. The myometrium and uterine cervix in normal and preterm labor
48. The ripening of the human uterine cervix in terms of connective tissue biochemistry
49. Prostaglandins, chorioamnionitis, and preterm labor
50. Prostaglandin E production by the fetal membranes in unexplained preterm labour and preterm labour associated with chorioamnionitis
51. n-6 and n-3 fatty acids during early human development
52. Oral administration of menhaden oil alters gestation in rates
53. 2 in the intrauterine tissues and the kidney
54. Longer gestation in rats fed diet supplemented with (n-3) fatty acids that in rats fed diet supplemented with (n-6) fatty acids
55. Possible roles of maternal and perinatal long-chain fatty acids in preterm birth
56. Prostaglandins in selected reproductive tissues in preterm and full term gestations
57. Maternal and perinatal long-chain fatty acids: Possible roles in preterm birth
58. Intake of marine fat, rich in (n-3) polyunsaturated fatty acids, may increase birthweight by prolonging gestation
59. Gestational age in relation to marine n-3 fatty acids in maternal erythrocytes: A study in the Faroe Islands and Denmark
60. Randomized controlled trial of effect of fish-oil supplementation on pregnancy duration
61. Effects of third trimester consumption of eggs high in docosahexaenoic acid on docsocahexaenoic acid status and pregnancy
62. Cardiovascular effects of n-3 fatty acids
63. Prevention of cardiac arrhythmia by dietary (n-3) polyunsaturated fatty acids and their mechanism of action
64. Effects of fish oil supplementation in the third trimester of pregnancy on prostacyclin and thromboxane production
65. A randomized, double-blind, placebo-controlled trial of fish oil in high risk pregnancy
66. Delay of preterm delivery in sheep by omega-3 long-chain polyunsaturates
67. Maternal administration of long-chain n-3 polyunsaturates to the pregnant ewe in late gestation results in specific inhibition of prostaglandin in synthetase (PGHS)2, but not PGHS1 and oxytocin receptor in RNA in myometrium during betamethasone induced labor
68. Changes in the breast milk fatty acids and plasma lipids of nursing mothers following consumption of n-3 polyunsaturated fatty acid enriched eggs
69. Neurologic differences between 9-year-old children fed breast milk or formula babies
70. Effect of long-chain polyunsaturated fatty acids in infant formula in problem solving at 10 months of age
71. Effects of maternal docosahexaenoic acid (DHA) supplemention on visual and neurodevelopmental function of breast-fed infants
72. Effect of long-chain n-3 fatty acid supplementation on visual acuity and growth of preterm infants with and without bronchopulmonary dysplasia
73. Diet during pregnancy and the risk of cerebral palsy
74. Relationship between breast-feeding and incidence rate of insulin-dependent diabetes mellitus: A hypothesis
75. The fatty acid composition of skeletal muscle membrane phospholipid: Its relationship with the type of feeding and plasma glucose levels in young children
76. Do cell membrane dynamics participate in insulin resistance?
77. N-3 polyunsaturated fatty acids inhibit the antigen-presenting function of human monocytes
78. The effect of dietary supplementation with ω-3 polyunsaturated fatty acids on the synthesis of interleukin-1 and tumor necrosis factor by mononuclear cells
79. Use of cod liver oil during pregnancy associated with lower risk of type I diabetes in the offspring
80. Maternal plasma phospholipid polyunsaturated fatty acids in pregnancy with and without gestational diabetes mellitus: Relations with maternal factors
81. Fetal origins of coronary artery disease
82. Essential fatty acids in correlation to pregnancy complications and fetal development
83. Teratogenicity from high vitamin A intake
84. Comparison between the essential fatty acid status of preterm and full term infants measured in umbilical vessel walls
85. The influence of maternal vegetarian diet on essential fatty acid status of the newborn